⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

April 1, 2026International Journal of Rheumatic Diseases

A Case Series: Real World Data on the Use of Anifrolumab in Patients With Systemic Lupus Erythematosus in Two Private Tertiary Hospitals in the Philippines

Cristina Dorado Melissa L. Aquno‐Villamin Aileen U. Agbanlog‐Dimatulac Juan Javier T Lichauco Evan S. Vista

View at Publisher

Ask AI

Bookmark

Share

Key Points

To evaluate the effectiveness and real-world application of anifrolumab in patients with systemic lupus erythematosus.
Conducted a case series at two private tertiary hospitals in the Philippines.
Collected data on patients receiving anifrolumab therapy.
Analyzed outcomes related to systemic lupus erythematosus.
Provided insights on the use of anifrolumab in clinical practice.
Identified potential benefits for patients based on collected data.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Implication

Case series investigates the impact of anifrolumab in patients with systemic lupus erythematosus, suggesting potential effectiveness.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Dorado et al. (2026) studied this question.

synapsesocial.com/papers/69d34e949c07852e0af9832b https://doi.org/10.1111/1756-185x.70635

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Anifrolumab for lupus erythematosus in real‐world practice: A Spanish national seriesOriginal Research · 2026 · 2 citations
2Anifrolumab in Refractory Systemic Lupus Erythematosus: A Real-World, Multicenter Study2024 · 22 citations
3Anifrolumab in systemic lupus erythematosus: real-world evidence from a Spanish multicentre cohort of 206 patients and literature reviewHuman Clinical Trial · 2026 · 2 citations
4LBP5 Real-life data of anifrolumab as a treatment for systemic lupus erythematosus (SLE)2024
5Real-world Evidence of Anifrolumab Use in Mexican Patients With Systemic Lupus Erythematosus: A Multicenter Observational StudyObservational Study · 2026

Real-world use of anifrolumab in systemic lupus erythematosus: A retrospective study from a Danish tertiary center (2022–2025)2026
Characteristics and clinical outcomes of patients with systemic lupus erythematosus initiating anifrolumab in a real-world setting in Spain (AZAHAR study): an observational study protocol2025
LBP6 Early access program experience of anifrolumab in systemic lupus erythematosus patients in a Portuguese single center cohort2024
Adapting an Interprofessional Medication Adherence Program for Gout (IMAP‐Gout): A Theory‐Informed Pre‐Implementation Analysis Using the Theoretical Domains Framework (TDF)International Journal of Rheumatic Diseases · 2026
Juvenile Dermatomyositis With Dual Myositis‐Specific Antibodies and Rapidly Progressive Interstitial Lung Disease: A Pediatric Case ReportInternational Journal of Rheumatic Diseases · 2026

More from International Journal of Rheumatic Diseases

More from St. Luke's Medical Center